About Curebase
Curebase is a company based in San Francisco (United States) founded in 2017. Curebase has raised $59.01 million across 4 funding rounds from investors including Gilead, Industry Ventures and Acrew Capital. Curebase offers products and services including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC. Curebase operates in a competitive market with competitors including L7 Informatics, MDClone, Clinical Research IO, THREAD and VivoSense, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Curebase, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$59.01 M (USD)
in 4 rounds
-
Latest Funding Round
$40 M (USD), Series B
May 05, 2022
-
Investors
Gilead
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curebase
Curebase offers a comprehensive portfolio of products and services, including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC.
Tools for electronic patient-reported outcomes in clinical trials.
Platform for paperless consent in multi-device clinical studies.
Integrated mobile system for study prescreening and data submission.
Unified platform for hybrid study data management and monitoring.
People of Curebase
Unlock access to complete
Funding Insights of Curebase
Curebase has successfully raised a total of $59.01M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $40.0M
-
First Round
First Round
(22 Aug 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series B - Curebase | Valuation | Industry Ventures | |
| Apr, 2021 | Amount | Series A - Curebase | Valuation | GGV Capital | |
| Oct, 2018 | Amount | Series A - Curebase | Valuation |
investors |
|
Investors in Curebase
Curebase has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Gilead, Industry Ventures and Acrew Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in private tech ecosystem are made by Industry Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by Acrew Capital venture firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on SaaS, mobile tech, AI, and multiple sectors
|
Founded Year | Domain | Location |
Investments & Acquisitions by Curebase
Financial Statements - Curebase
Curebase Comparisons
Competitors of Curebase
Curebase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as L7 Informatics, MDClone, Clinical Research IO, THREAD and VivoSense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical trial workflow management software is provided for laboratories.
|
|
| domain | founded_year | HQ Location |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| domain | founded_year | HQ Location |
Clinical trial management software is provided for research sites.
|
|
| domain | founded_year | HQ Location |
Provider of patient research studies software
|
|
| domain | founded_year | HQ Location |
Wearable sensor research analysis platform
|
Frequently Asked Questions about Curebase
Curebase was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Curebase is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Storm Stillman is the current CEO of Curebase.
Curebase is a funded company, having raised a total of $59.01M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.51M, raised on Aug 22, 2018.
Curebase was founded in 2017 in San Francisco, United States, within the clinical research sector. A platform is operated to facilitate patient enrollment and engagement for decentralized trials. Eligibility screening, enrollment processes, participant education, and consent management are streamlined. In-app guidance on protocols is delivered to users, alongside capabilities for document scanning and upload. Operations focus on enhancing trial conduction efficiency.
Curebase's top competitors include L7 Informatics, Sonrai Analytics and MDClone.
Curebase offers ePRO/eCOA, eConsent, Unified Participant Experience, and EDC.
Curebase has 10 investors. Key investors include Gilead, Industry Ventures, Acrew Capital, World Innovation Lab, and Positive Sum.